Re: Schelfhout J, Bonafede M, Cappell K, et al. Impact of cytomegalovirus complications on resource utilization and costs following hematopoietic stem cell transplant. Curr Med Res Opin. 2020; 36(1):33–41. Schelfhout J, Brown H, House JA, Raval AD. Cytomegalovirus infection and associated hospitalization and costs among individuals undergoing allogeneic hematopoietic stem cell transplant. Curr Med Res Opin. 2020;36(1):43–50.
Küçük Resim Yok
Tarih
2020
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Taylor and Francis Ltd
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
[No abstract available]
Açıklama
Anahtar Kelimeler
Ganciclovir; Valaciclovir; Virus Dna; Acute Leukemia; Adult; Aged; Allogeneic Hematopoietic Stem Cell Transplantation; Cytomegalovirus Infection; Female; Hospital Readmission; Hospitalization Cost; Human; Infection Prevention; Letter; Lymphoma; Major Clinical Study; Male; Myeloablative Conditioning; Myeloma; Nonhuman; Reduced Intensity Conditioning; Retrospective Study; Survival; Virus Reactivation; Cost; Cytomegalovirus; Cytomegalovirus Infection; Hematopoietic Stem Cell Transplantation; Hospitalization; Costs And Cost Analysis; Cytomegalovirus; Cytomegalovirus Infections; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans
Kaynak
Current Medical Research and Opinion
WoS Q Değeri
Scopus Q Değeri
Q2
Cilt
36
Sayı
4
